KOPRAN
₹101.4
-3.4 (-3.24%)
As on 25 March, 2023 | 13:35 BSE: 524280 NSE: KOPRAN

Kopran Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in Kopran

Start SIP

Kopran Share Price

  • Over 1 Month -11.05%
  • Over 3 Month -33.51%
  • Over 6 Month -39.03%
  • Over 1 Year -66.58%

Kopran Key Statistics

P/E Ratio 13.3
PEG Ratio -0.4
Market Cap Cr 489
Price to Book Ratio 1.1
EPS 2.4
Dividend 3
Relative Strength Index 32.23
Money Flow Index 58.33
MACD Signal -5.67
Average True Range 6.58

Kopran Investment Rating

  • Master Rating:
  • Kopran has an operating revenue of Rs. 538.52 Cr. on a trailing 12-month basis. An annual revenue de-growth of -4% needs improvement, Pre-tax margin of 17% is great, ROE of 14% is good. The company has a reasonable debt to equity of 4%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 48 which is a POOR score indicating inconsistency in earnings, a RS Rating of 3 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D- which indicates heavy supply, Group Rank of 91 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Kopran Financials
IndicatorDec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 68547064
Operating Expenses Qtr Cr 62486458
Operating Profit Qtr Cr 6667
Depreciation Qtr Cr 1111
Interest Qtr Cr 1101
Tax Qtr Cr 1112
Net Profit Qtr Cr 41845

Kopran Technicals

EMA & SMA

Current Price
₹101.4
-3.4 (-3.24%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 16
  • 20 Day
  • 110.3
  • 50 Day
  • 121.61
  • 100 Day
  • 137.18
  • 200 Day
  • 161.16
  • 20 Day
  • 109.13
  • 50 Day
  • 122.37
  • 100 Day
  • 140.13
  • 200 Day
  • 163.38

Kopran Resistance and Support

PIVOT
₹106.7
Resistance
First Resistance 109.1
Second Resistance 113.4
Third Resistance 115.8
RSI 32.23
MFI 58.33
MACD Single Line -5.67
MACD -5.52
Support
First Resistance 102.4
Second Resistance 100
Third Resistance 95.7

Kopran Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 311,149 14,633,337 47.03
Week 369,956 22,881,779 61.85
1 Month 380,677 19,772,349 51.94
6 Month 237,468 10,683,698 44.99

Kopran Result Highlights

Kopran Synopsis

NSE-Medical-Diversified

Kopran Ltd is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 204.52 Cr. and Equity Capital is Rs. 48.21 Cr. for the Year ended 31/03/2022. Kopran Ltd. is a Public Limited Listed company incorporated on 26/04/1958 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24230MH1958PLC011078 and registration number is 011078.
Market Cap 489
Sales 256
Shares in Float 2.70
No of funds 15
Yield 2.86
Book Value 1.29
U/D Vol ratio 0.9
LTDebt / Equity 1
Alpha -0.34
Beta 0.95

Kopran

Owner NameDec-22Sep-22Jun-22Mar-22
Promoters 44.3%44.25%44.25%
Mutual Funds
Insurance Companies 0.14%0.14%0.14%
Foreign Portfolio Investors 0.34%0.51%0.5%
Financial Institutions/ Banks
Individual Investors 39.51%39.53%39.89%
Others 15.71%15.57%15.22%

Kopran Management

Name Designation
Mr. Susheel G Somani Chairman
Mr. Surendra Somani Executive Vice Chairman
Mr. Adarsh Somani Director
Mr. Varun Somani Director
Dr. Siddhan Subramanian Independent Director
Dr. Sunita Banerji Independent Director
Mrs. Mamta Biyani Independent Director
Mr. Narayan Atal Independent Director

Kopran Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Kopran MF Shareholding

Name Amount(cr)
Motilal Oswal S&P BSE Healthcare ETF 6

Kopran FAQs

What is Share Price of Kopran ?

Kopran share price is ₹101 As on 25 March, 2023 | 13:21

What is the Market Cap of Kopran ?

The Market Cap of Kopran is ₹488.9 Cr As on 25 March, 2023 | 13:21

What is the P/E ratio of Kopran ?

The P/E ratio of Kopran is 13.3 As on 25 March, 2023 | 13:21

What is the PB ratio of Kopran ?

The PB ratio of Kopran is 1.1 As on 25 March, 2023 | 13:21

Q2FY23

Start Investing Now!

Open Free Demat Account in 5 mins

Enter Valid Mobile Number